Forbes April 10, 2024
The continued evolution of SARS-CoV-2 into new variants, each as or more infectious than the last, underscores the ongoing need to update our vaccine defenses against the virus. While updated vaccines work against the variant for which they are designed, the virus quickly evolves to become more infectious and evade our latest immune defenses. This dynamic underscores the need for a universal vaccine, a potential game-changer that could neutralize all forms of SARS-CoV-2 and even other related coronaviruses. A recent study by Peter Halfmann and colleagues from the University of Wisconsin offers promising indications that this universal vaccine is on the horizon.
Over the four years and many millions of deaths, since the virus emerged in early 2020, we have...
Today's Sponsors
Today's Sponsor